Time-Dependent Changes in Risk of Progression During Use of Bevacizumab for Ovarian Cancer

IMPORTANCE: Although bevacizumab has been used in the treatment of ovarian cancer, its optimal use is unknown. OBJECTIVE: To investigate time-dependent changes in the outcomes of bevacizumab therapy. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted using published data from 7 previ...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamatsu, Shiro, Nakai, Hidekatsu, Yamaguchi, Ken, Hamanishi, Junzo, Mandai, Masaki, Matsumura, Noriomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398412/
https://www.ncbi.nlm.nih.gov/pubmed/37531111
http://dx.doi.org/10.1001/jamanetworkopen.2023.26834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398412/
https://www.ncbi.nlm.nih.gov/pubmed/37531111
http://dx.doi.org/10.1001/jamanetworkopen.2023.26834

Ejemplares similares